Cancer

Top in hem/onc: New breast cancer treatment, CAR T-cell therapy for lymphoma

Last week, the FDA approved margetuximab-cmkb for the treatment of patients with metastatic HER2-positive breast cancer. It was the top story in …

Read more

Show More

Related Articles

Back to top button